Last reviewed 2026-04-20 · How we verify

Chuanhong Zhongfeng capsule

Yingyue Ding · Phase 1 active Small molecule Quality 0/100

Chuanhong Zhongfeng capsule is a Small molecule drug developed by Yingyue Ding. It is currently in Phase 1 development.

At a glance

Generic name	Chuanhong Zhongfeng capsule
Sponsor	Yingyue Ding
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Chuanhong Zhongfeng capsule CI brief — competitive landscape report
Chuanhong Zhongfeng capsule updates RSS · CI watch RSS
Yingyue Ding portfolio CI

Frequently asked questions about Chuanhong Zhongfeng capsule

What is Chuanhong Zhongfeng capsule?

Chuanhong Zhongfeng capsule is a Small molecule drug developed by Yingyue Ding.

Who makes Chuanhong Zhongfeng capsule?

Chuanhong Zhongfeng capsule is developed by Yingyue Ding (see full Yingyue Ding pipeline at /company/yingyue-ding).

What development phase is Chuanhong Zhongfeng capsule in?

Chuanhong Zhongfeng capsule is in Phase 1.

Manufacturer: Yingyue Ding — full pipeline
Compare: Chuanhong Zhongfeng capsule vs similar drugs
Pricing: Chuanhong Zhongfeng capsule cost, discount & access